Melatonin antagonizes oxidative stress-induced apoptosis in retinal ganglion cells through activating the

Shan Gao1, Qiaochu Cheng1, Yaguang Hu1

  • 1Department of Ophthalmology, the First Affiliated Hospital of Xi'an Jiaotong University, No.277 Yanta West Road, Yanta District, Xi'an, 710061, Shaanxi, China.

PubMed

Insights

Melatonin protects retinal ganglion cells from oxidative stress by modulating the Thioredoxin-1 (Trx1)-mediated c-Jun N-terminal kinase (JNK) pathway, reducing cell death and damage.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Cell Biology

Background:

  • Oxidative stress is a key factor in retinal ganglion cell (RGC) injury.
  • Understanding protective mechanisms against RGC damage is crucial for treating vision loss.

Purpose of the Study:

  • To investigate melatonin's protective role against oxidative stress in RGCs.
  • To elucidate the underlying molecular mechanisms involving Thioredoxin-1 (Trx1) and c-Jun N-terminal kinase (JNK) signaling.

Main Methods:

  • RGC-5 cells were exposed to hydrogen peroxide (H₂O₂) to induce oxidative injury.
  • Cell viability, apoptosis, reactive oxygen species (ROS), lactate dehydrogenase (LDH), and malondialdehyde (MDA) were assessed.
  • Thioredoxin-1 (Trx1) was silenced using siRNA, and JNK signaling was inhibited with compound C.

Main Results:

  • Melatonin pre-treatment significantly reduced H₂O₂-induced apoptosis and oxidative stress markers (ROS, LDH, MDA) in RGCs.
  • Melatonin reversed apoptosis-related protein expression changes and normalized antioxidant enzyme levels.
  • Trx1 knockdown diminished melatonin's protective effects, while JNK inhibition partially restored them.

Conclusions:

  • Melatonin confers significant protection to retinal ganglion cells against oxidative stress-induced injury.
  • This protection is mediated through the Thioredoxin-1 (Trx1)-dependent modulation of the c-Jun N-terminal kinase (JNK) signaling pathway.